Insulin signaling and its regulation of system A amino acid uptake in cultured rat vascular smooth muscle cells

Circulation Research

Volumn 79, Issue 6, 1996, Pages 1167-1176

  Obata, Toshiyuki ^a   Kashiwagi, Atsunori ^a   Maegawa, Hiroshi ^a   Nishio, Yoshihiko ^a   Ugi, Satoshi ^a   Hidaka, Hideki ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

insulin; vascular smooth muscle cell; wortmannin; aminoisobutyric acid

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN C; WORTMANNIN;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ENZYME ACTIVITY; HYPERINSULINEMIA; IMMUNOBLOTTING; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0029806961     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.6.1167     Document Type: Article

References (51)

1. Fontbonne A, Tchobroutsky G, Eschwege E, Richards JL, Claude JR, Rosselin GE. Coronary heart disease mortality risk factor: plasma insulin level is a more sensitive marker than hypertension or abnormal glucose tolerance in overweight males: the Paris Prospective Study. Int J Obes. 1988;12:557-565.
2. Pyorala K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 91/2-year follow-up of the Helsinki Policeman Study population. Acta Med Scand. 1985;701:38-52.
3. Cullen K, Stenhouse NS, Wearne KL, Welborn TA. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13-year study. J Chronic Dis. 1983;36:371-377.
4. Reaven GM. Banting lecture 1988: role of insulin resistance inhuman disease. Diabetes. 1988;37:1595-1607.
5. Stout RW. Insulin and atheroma, 20-yr perspective. Diabetes Care. 1990;13:631-654.
6. Takagi Y, Kashiwagi A, Tanaka Y, Maegawa H, Shigeta Y. Insulin-specific activation of S6 kinase and its desensitization in cultured rat vascular smooth muscle cells. Atherosclerosis. 1995;113:19-27.
7. r-185,000 protein in intact cells. Nature. 1985;318:183-186.
8. Skolnik EY, Lee C-H, Batzer A, Vicentini LM, Zhou M, Daly R, Myers MG Jr, Backer JM, Ullrich A, White MF, Schlessinger J. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS-1 and Shc: implications for insulin control of ras signalling. EMBO J. 1993;12:1929-1936.
9. Tobe K, Matsuoka K, Tamemoto H, Ueki K, Kaburagi Y, Asai S, Noguchi T, Matsuda M, Tanaka S, Hattori S, Fukui Y, Akanuma Y, Yazaki Y, Takenawa T, Kadowaki T. Insulin stimulates association of insulin receptor substrate-1 with the protein abundant src homology/growth factor-bound protein-2. J Biol Chem. 1993;268:11167-11171.
10. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 1991;352:73-77.
11. Skolnik EY, Batzer A, Li N, Lee C-H, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J. The function of GRB2 in linking the insulin receptor to ras signaling pathways. Science. 1993;260:1953-1955.
12. Moodie SA, Willumsen BM, Weber MJ, Wolfman A. Complexes of ras GTP with raf-1 and mitogen-activated protein kinase kinase. Science. 1993;260:1658-1661.
13. Kyriakis JM, App H, Zhang HF, Banerjee P, Brautigam DL, Rapp UR, Avruch J. Raf-1 activates MAP kinase-kinase. Nature. 1992;358:417-421.
14. Sun H, Charles CH, Lau LF, Tonk NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 1993;75:487-493.
15. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transport. Mol Cell Biol. 1994;14:4902-4911.
16. Okada T, Kawani Y, Sakakibara T, Hazeki O, Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes: studies with a selective inhibitor wortmannin. J Biol Chem. 1994;269:3568-3573.
17. S6K activation mediated by phosphatidyl-inositol-3-OH kinase. Nature. 1994;370:71-74.
18. Weng QP, Andrabi K, Klippel A, Kozlowski MT, Williams LT, Avruch J. Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc Natl Acad Sci U S A. 1995;92:5744-5748.
19. Erikson RL. Structure, expression, and regulation of protein kinases involved in the phosphorylation of ribosomal protein S6. J Biol Chem. 1991;266:6007-6010.
20. Sturgill TW, Ray LB, Erikson E, Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature. 1988;334:715-719.
21. Ballou LM, Luther H, Thomas G. MAP2 kinase and p70 S6 kinase lie on distinct signalling pathways. Nature. 1991;349:348-350.
22. Ming H-F, Burgering BMT, Wennstrom S, Claesson-Welsh L, Heldin C-H, Bos JL, Kozma SC, Thomas G. Activation of p70/p85 S6 kinase by a pathway independent of p21ras. Nature. 1994;371:426-429.
23. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinase. Cell. 1992;69:1227-1236.
24. Price DJ, Grove JR, Calvo V, Avruch J, Bierer BE. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science. 1992;257:973-977.
25. McGivan JD, Pastor-Anglada M. Regulatory and molecular aspects of mammalian amino acid transport. Biochem J. 1994;299:321-334.
26. Ugi S, Maegawa H, Olefski JM, Shigeta Y, Kashiwagi A. Src homology 2 domains of protein tyrosine phosphatase are associated in vitro with both the insulin receptor and insulin receptor substrate-1 via different phosphotyrosine motifs. FEBS Lett. 1994;340:216-220.
27. S6K function is essential for G1 progression. Science. 1993;363:170-172.
28. Kozma SC, Ferrari S, Bassand P, Siegmann M, Totty N, Thomas G. Cloning of the mitogen-activated S6 kinase from rat liver reveals an enzyme of the second messenger subfamily. Proc Natl Acad Sci U S A. 1990;87:7365-7369.
29. Alcorta DA, Crews CM, Sweet LJ, Bankston L, Jones SW, Erikson RL. Sequence and expression of chicken and mouse rsk: homologs of xenopus laevis ribosomal S6 kinase. Mol Cell Biol. 1989;9:3850-3859.
30. Pelech SL, Olwin BB, Krebs EG. Fibroblast growth factor treatment of Swiss 3T3 cells activates a subunit S6 kinase that phosphorylates a synthetic peptide substrate. Proc Natl Acad Sci U S A. 1986;83:5968-5972.
31. Takata Y, Kobayashi M, Maegawa H, Watanabe N, Ishibashi O, Shigeta Y, Fujimi Y. A primary defect in insulin receptor in a young male patient with insulin receptor with insulin resistance. Metabolism. 1986;35:950-955.
32. Okamoto M, Hayashi T, Kono S, Inoue G, Kubota M, Okamoto M, Kuzuya H, Imura H. Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation. Biochem J. 1993;290:327-333.
33. Laemmli UK. Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
34. Maegawa H, Ide R, Hasegawa M, Ugi S, Egawa K, Iwanishi M, Kikkawa R, Shigeta Y, Kashiwagi A. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J Biol Chem. 1995;270:7724-7730.
35. Posoda J, Cooper JA. Requirements for phosphorylation of MAP kinase during meiosis in xenopus oocytes. Science. 1992;255:212-215.
36. Denton RM, Tavare JM. Does mitogen-activated protein kinase have a role in insulin action? Eur J Biochem. 1995;227:597-661.
37. Elder-Finkelman H, Segar R, Vandenheede JR, Krebs EG. Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J Biol Chem. 1995;270:987-990.
38. Segar R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9:726-735.
39. Downward J. Regulating S6 kinase. Nature. 1994;371:378-379.
40. Ferrer-Martinez A, Casado J, Leturque A, Felipe A, Pastor-Anglada M. Up-regulation of liver system A amino acid transport in euglycemic hyperinsulinemic rats. Biochim Biophys Acta. 1994;1222:63-69.
41. Marumo T, Nakaki T, Hishikawa K, Suzuki H, Kato R, Saruta T. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension. 1995;25:764-768.
42. Hu ZW, Shi XY, Okazaki M, Hoffman BB. Angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells. Am J Physiol. 1995;268:H1006-H1014.
43. Izzo NJ, Tulenko TN, Colucci WS. Phorbol ester and norepinephrine destabilize alpha 1B-adrenergic receptor mRNA in vascular smooth muscle cells. J Biol Chem. 1994;269:1705-1710.
44. Pilola CJ, Wang HM, Kamyar A, Wu S, Enomoto H, Sharifi B, Forrester JS, Clemens TL, Fagin JA. Angiotensin II regulates parathyroid hormone-related protein expression in cultured rat aortic smooth muscle cells through transcriptional and post-transcriptional mechanisms. J Biol Chem. 1993;268:1987-1994.
45. Cross MJ, Stewart A, Hodgkin MN, Kerr DJ, Wakelam MJ. Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. J Biol Chem. 1995;270:25352-25355.
46. S6K: functional requirement for entry into S phase. EMBO J. 1994;13:1557-1565.
47. Shepherd PR, Nave BT, Siddle K. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphatidylinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem J. 1995;305:25-28.
48. Lin TA, Kong X, Saltiel AR, Blackshear PJ, Lawrence JC Jr. Control of PHAS by insulin in 3T3-L1 adipocyte. J Biol Chem. 1995;270:18531-18538.
49. Terada N, Patel HR, Takase K, Kohno K, Nairin AC, Gelfand EW. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci U S A. 1994;91:11477-11481.
50. Giasson E, Meloche S. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. J Biol Chem. 1995;270:5225-5231.
51. Groot RP, Ballow LM, Sassone-Corsi P. Positive regulation of the cAMP-responsive activator CREM by p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell. 1994;79:81-91.